EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Microbial serotonin signalling axes in irritable bowel syndrome: integrative molecular crosstalk among enterochromaffin cells, gut microbiota, neuroimmune circuits, and precision therapeutic engineering

Ravinder Kumar Mehra, Bhanu Pratap Singh, Shakir Siddiqui, Mohammed F Aldawsari, Mohammad Azhar Kamal, Md Khalid Anwer iD

Archives of Microbiology · 2027

DOI: 10.1007/s00203-026-05250-5 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Archives of Microbiology, 2027. Verfasst von Ravinder Kumar Mehra und 5 weiteren Autor:innen. Beteiligte Einrichtung: Geeta Institute of Pharmacy, Geeta University, Naultha, Panipat, Haryana, India. Hauptthemen laut MEDLINE: Irritable Bowel Syndrome, Serotonin, Enterochromaffin Cells, Gastrointestinal Microbiome. Die Arbeit nennt 79 Literaturangaben. Gefördert von: Prince Sattam bin Abdulaziz University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Irritable bowel syndrome (IBS) is a common, often disabling disorder of gut-brain interaction whose molecular basis remains incompletely defined, leaving diagnosis largely symptom-based and treatment largely non-mechanistic. We argue that the serotonin (5-hydroxytryptamine; hereafter 5-HT, the primary term used throughout, with "serotonin" retained in less technical contexts) signalling axis-positioned at the interface of the gut microbiota, enterochromaffin (EC) cells, enteric neurons, and the mucosal immune system-is a central, unifying integrator of IBS pathophysiology, and that reframing IBS around this axis offers a route toward mechanism-based subtyping and therapy. We first synthesise how microbiota-driven tryptophan metabolism, short-chain fatty acid and secondary bile acid signalling, and epigenetic regulation of tryptophan hydroxylase 1 (TPH1) shape EC-cell serotonin output, before examining the neuroimmune consequences of dysregulated serotonin secretion-mast cell activation, macrophage polarisation, neurogenic inflammation-and the microbiota-serotonin-gut-brain connectome linking vagal afferent signalling, blood-brain barrier permeability, and central neurotransmitter networks. We then discuss molecular stratification of IBS subtypes through serotonergic endotyping-incorporating SLC6A4 and TPH1 polymorphisms, single-cell transcriptomics, and spatial metabolomics-and critically evaluate next-generation therapeutic strategies, including engineered probiotic chassis, CRISPR-mediated microbial editing, and AI-guided nanomedicine, distinguishing proof-of-concept findings from clinically validated approaches. We conclude that reconceptualising IBS as a disorder of disrupted microbial serotonergic ecosystems, rather than a purely symptom-defined syndrome, offers a coherent and testable framework for biomarker discovery and precision, mechanism-directed therapy, while highlighting the causal-directionality and clinical-translation gaps that must be closed before this framework can be applied at the bedside.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Irritable Bowel SyndromeSerotoninEnterochromaffin CellsGastrointestinal MicrobiomeHumansAnimalsSignal TransductionNeuroimmunomodulationTryptophan HydroxylaseTryptophan

Stichwörter der Autor:innen

5-HTEnterochromaffin cellsGut microbiotaGut–brain axisIrritable bowel syndromeNeuroimmunePrecision medicineSerotoninTPH1Tryptophan metabolism

Substanzen

SerotoninTryptophan HydroxylaseTryptophan

Autor:innen und Institutionen

  • Geeta Institute of Pharmacy, Geeta University, Naultha, Panipat, Haryana, India.
  • Department of Pharmacology, School of Pharmacy, Krishna Institute of Engineering and Technology (KIET), Ghaziabad, Delhi-NCR, Uttar Pradesh, India.
  • Department of Pharmacology, Saras College of Pharmacy, Sarora, Baghpat, Uttar Pradesh, India.
  • Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, 11942, Saudi Arabia.
  • Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Alkharj, 11942, Saudi Arabia. m.anwer@psau.edu.sa.

ORCID-Profile: Md Khalid Anwer

Förderung

  • Prince Sattam bin Abdulaziz University

Zitieren

APA

Mehra, R. K., Singh, B. P., Siddiqui, S., Aldawsari, M. F., Kamal, M. A., & Anwer, M. K. (2027). Microbial serotonin signalling axes in irritable bowel syndrome: integrative molecular crosstalk among enterochromaffin cells, gut microbiota, neuroimmune circuits, and precision therapeutic engineering. Archives of Microbiology. https://doi.org/10.1007/s00203-026-05250-5

Vancouver

Mehra RK, Singh BP, Siddiqui S, Aldawsari MF, Kamal MA, Anwer MK. Microbial serotonin signalling axes in irritable bowel syndrome: integrative molecular crosstalk among enterochromaffin cells, gut microbiota, neuroimmune circuits, and precision therapeutic engineering. Archives of Microbiology. 2027. doi:10.1007/s00203-026-05250-5

BibTeX
@article{Mehra2027,
  author = {Mehra, Ravinder Kumar and Singh, Bhanu Pratap and Siddiqui, Shakir and Aldawsari, Mohammed F and Kamal, Mohammad Azhar and Anwer, Md Khalid},
  title = {Microbial serotonin signalling axes in irritable bowel syndrome: integrative molecular crosstalk among enterochromaffin cells, gut microbiota, neuroimmune circuits, and precision therapeutic engineering},
  journal = {Archives of Microbiology},
  year = {2027},
  doi = {10.1007/s00203-026-05250-5}
}
Kostenlos starten →